CRISPR-Cas9 gene editing of inhibitory receptor signaling pathways improves CAR T cell activity against glioblastoma

被引：0
|
作者：
Sanber, Khaled [1 ]
Nawas, Zeid [1 ]
Salsman, Vita [1 ]
Gad, Ahmed [1 ]
Matthew, Pretty Rose [1 ]
Landi, Daniel [1 ]
Lee, Ciaran [2 ]
Sengal, Amel [1 ]
Chakraborty, Rikhia [1 ]
Joseph, Sujith [1 ]
Nabil, Ahmed [1 ]
Hegde, Meenakshi [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Rice Univ, Houston, TX USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-2173
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2173
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Receptor-Mediated Delivery of CRISPR-Cas9 Endonuclease for Cell Type Specific Gene Editing
    Roy, Marc
    Rouet, Romain
    Thuma, Benjamin
    Lintner, Nathanael
    Rubitski, David
    Finley, James
    Wisniewska, Hanna
    Mendonsa, Rima
    de Onate, Lorena
    Hirsh, Ariana
    Barron, Joan Compte
    McLellan, Thomas
    Bellenger, Justin
    Feng, Xidong
    Varghese, Alison
    Chrunyk, Boris
    Borzilleri, Kris
    Hesp, Kevin
    FASEB JOURNAL, 2018, 32 (01):
  • [22] Application of CRISPR-Cas9 gene editing to treat HBV
    Yan, Kun
    Feng, Jiangpeng
    Xiong, Yong
    Chen, Yu
    CHINESE SCIENCE BULLETIN-CHINESE, 2019, 64 (30): : 3142 - 3150
  • [23] CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
    Rim, John Hoon
    Gopalappa, Ramu
    Gee, Heon Yung
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (18): : 1722 - 1722
  • [24] CRISPR-cas9 gene editing in undergraduate laboratory experience
    Kee, H. Lynn
    Pieczynski, Jay
    FASEB JOURNAL, 2019, 33
  • [25] Gene editing for the treatment of lung cancer (CRISPR-Cas9)
    Castillo, Andres
    COLOMBIA MEDICA, 2016, 47 (04): : 178 - 180
  • [26] Treatment by CRISPR-Cas9 Gene Editing - A Proof of Principle
    Malech, Harry L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (03): : 286 - 287
  • [27] NOBEL PRIZE FOR CHEMISTRY Gene Editing with CRISPR-Cas9
    Welter, Kira
    CHEMIE IN UNSERER ZEIT, 2020, 54 (06) : 346 - 350
  • [28] CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
    Gillmore, Julian D.
    Gane, Ed
    Taubel, Jorg
    Kao, Justin
    Fontana, Marianna
    Maitland, Michael L.
    Seitzer, Jessica
    O'Connell, Daniel
    Walsh, Kathryn R.
    Wood, Kristy
    Phillips, Jonathan
    Xu, Yuanxin
    Amaral, Adam
    Boyd, Adam P.
    Cehelsky, Jeffrey E.
    McKee, Mark D.
    Schiermeier, Andrew
    Harari, Olivier
    Murphy, Andrew
    Kyratsous, Christos A.
    Zambrowicz, Brian
    Soltys, Randy
    Gutstein, David E.
    Leonard, John
    Sepp-Lorenzino, Laura
    Lebwohl, David
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (06): : 493 - 502
  • [29] Gene editing by SSB/CRISPR-Cas9 ribonucleoprotein in bacteria
    Chai, Ran
    Sun, Wenying
    Xu, Zhixu
    Yao, Xinding
    Chen, Shanshan
    Wang, Haifeng
    Guo, Jiaxiang
    Zhang, Qi
    Yang, Yanqing
    Li, Tao
    Chen, Shichang
    Qiu, Liyou
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 278
  • [30] Targeted Gene Editing using CRISPR-Cas9 for Modulation of Liver Cancer Signaling Pathways: Promising in vitro Findings
    Ibrahim, Lobna
    Hassan, Rania
    Radwan, Sara
    Hamdy, Nadia M.
    Elhefnawi, Mahmoud
    BIOCHEMISTRY AND CELL BIOLOGY, 2023, 101 (06)
12345